-
Crescent Capital BDC, Inc. Reports December 31, 2022 Financial Results; Declares a First Quarter 2023 Regular Dividend of $0.41 per Share
来源: Nasdaq GlobeNewswire / 22 2月 2023 16:30:00 America/New_York
LOS ANGELES, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $59.7 million, or $1.93 per share, and adjusted net investment income of $53.4 million, or $1.73 per share, for the year ended December 31, 2022. For the quarter ended December 31, 2022, net investment income was $16.1 million, or $0.52 per share, and adjusted net investment income was $15.0 million, or $0.49 per share.1 Reported net asset value per share was $19.83 at December 31, 2022.
The Company announced that its Board of Directors declared a regular cash dividend for the first quarter of 2023 of $0.41 per share, which will be paid on April 17, 2023 to stockholders of record as of the close of business on March 31, 2023.
Selected Financial Highlights
($ in millions, except per share amounts)As of and for the three months ended December 31, 2022 September 30, 2022 December 31, 2021 Investments, at fair value $ 1,263.0 $ 1,292.9 $ 1,270.4 Total assets $ 1,302.9 $ 1,339.3 $ 1,317.8 Total net assets $ 612.5 $ 622.6 $ 652.3 Net asset value per share $ 19.83 $ 20.16 $ 21.12 Investment income $ 34.6 $ 29.0 $ 24.1 Net investment income $ 16.1 $ 16.0 $ 12.5 Net realized gains (losses), net of taxes $ (0.0 ) $ (2.5 ) $ (0.4 ) Net change in unrealized gains (losses), net of taxes $ (13.5 ) $ (15.8 ) $ 0.7 Net increase (decrease) in net assets resulting from operations $ 2.6 $ (2.4 ) $ 12.8 Net investment income per share $ 0.52 $ 0.52 $ 0.42 Net realized gains (losses) per share, net of taxes $ (0.00 ) $ (0.08 ) $ (0.01 ) Net change in unrealized gains (losses) per share, net of taxes $ (0.44 ) $ (0.51 ) $ 0.02 Net increase (decrease) in net assets resulting from operations per share $ 0.08 $ (0.08 ) $ 0.44 Regular distributions paid per share $ 0.41 $ 0.41 $ 0.41 Special distributions paid per share — $ 0.05 $ 0.05 Non-GAAP Financial Measures1: Adjusted net investment income $ 15.0 $ 13.0 $ 12.7 Adjusted net investment income per share $ 0.49 $ 0.42 $ 0.43 Weighted average yield on income producing securities (at cost)2 10.8 % 9.5 % 7.5 % Percentage of debt investments at floating rates 98.8 % 98.7 % 98.5 % Portfolio & Investment Activity
As of December 31, 2022 and 2021, the Company had investments in 129 and 134 portfolio companies with an aggregate fair value of $1,263.0 and $1,270.4 million, respectively. The portfolio at fair value was comprised of the following asset types:
Portfolio Asset Types: As of December 31, $ in millions 2022 2021 Investment Type Fair Value Percentage Fair Value Percentage Senior secured first lien $ 301.0 23.8 % $ 329.9 26.0 % Unitranche first lien3 824.1 65.2 731.0 57.5 Unitranche first lien - last out3 13.8 1.1 13.7 1.1 Senior secured second lien 60.9 4.8 72.7 5.7 Unsecured debt 4.5 0.4 5.6 0.4 Equity & other 44.9 3.6 59.5 4.7 LLC/LP equity interests 13.8 1.1 58.0 4.6 Total investments $ 1,263.0 100.0 % $ 1,270.4 100.0 %
Full YearFor the year ended December 31, 2022, the Company invested $308.0 million across 20 new portfolio companies, 31 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $277.6 million in aggregate exits, sales and repayments. For the year ended December 31, 2021, the Company invested $647.4 million across 46 new portfolio companies, 48 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $461.3 million in aggregate exits, sales and repayments.
Fourth Quarter
For the quarter ended December 31, 2022, the Company invested $45.9 million across 5 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $71.5 million in aggregate exits, sales and repayments. For the quarter ended September 30, 2022, the Company invested $89.8 million across 7 new portfolio companies, 9 existing portfolio companies and several follow-on revolver and delayed draw fundings. For this period, the Company had $59.7 million in aggregate exits, sales and repayments.
Results of Operations
Full Year
For the year ended December 31, 2022, investment income totaled $116.7 million, an increase from $94.0 million for the year ended December 31, 2021. The increase was primarily driven by an increase in interest income from investments due to a rise in benchmark rates. Interest income, which includes amortization of upfront fees, increased from $85.7 million for the year ended December 31, 2021 to $108.5 million for the year ended December 31, 2022. Included in interest from investments for the year ended December 31, 2022 and 2021 are $2.4 million and $8.0 million of accelerated accretion of OID related to paydown activity, respectively. Dividend income increased from $7.5 million for the year ended December 31, 2021 to $7.7 million for the year ended December 31, 2022 due to higher distributions from portfolio companies. Other income, which includes consent, waiver, amendment, agency, underwriting and arranger fees associated with our investment activities, decreased from $0.8 million for the year ended December 31, 2021 to $0.5 million for the year ended December 31, 2022 due to lower amendment fees received.
For the years ended December 31, 2022 and 2021, total expenses, including income and excise taxes, totaled $57.0 million and $46.4 million, respectively. Interest and other debt financing costs increased from $19.8 million for the year ended December 31, 2021 to $31.9 million for the year ended December 31, 2022, due to higher weighted average debt outstanding and a higher weighted average cost of debt primarily attributable to the rise in benchmark rates.
Fourth Quarter
For the quarter ended December 31, 2022, investment income totaled $34.6 million, an increase from $29.0 million for the quarter ended September 30, 2022. The increase was primarily driven by an increase in interest income from investments due to a rise in benchmark rates. Interest income, which includes amortization of upfront fees, increased from $27.2 million for the quarter ended September 30, 2022 to $32.8 million for the quarter ended December 31, 2022.
For the quarter ended December 31, 2022, total expenses, including income and excise taxes, totaled $18.5 million, an increase from $13.0 million for the quarter ended September 30, 2022. Interest and other debt financing costs increased from $8.7 million for the quarter ended September 30, 2022 to $11.2 million for the quarter ended December 31, 2022, due to a higher weighted average cost of debt primarily attributable to the rise in benchmark rates.
Liquidity and Capital Resources
As of December 31, 2022, the Company had $17.1 million in cash and cash equivalents and restricted cash and $225.2 million of undrawn capacity on its credit facilities, subject to borrowing base and other limitations. The weighted average interest rate on the Company’s debt outstanding as of December 31, 2022 was 6.23%.
The Company’s debt to equity ratio was 1.08x as of December 31, 2022.
Non-GAAP Financial Measures
On a supplemental basis, the Company is disclosing adjusted net investment income and adjusted net investment income per share, each of which is a financial measure that is calculated and presented on a basis of methodology other than in accordance with U.S. GAAP (“non-GAAP”). Adjusted net investment income represents net investment income, excluding capital gains incentive fees. We use this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believe that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends without giving effect to capital gains incentive fees. The Company’s investment advisory agreement provides that a capital gains-based incentive fee is determined and paid annually with respect to realized capital gains (but not unrealized capital appreciation) to the extent such realized capital gains exceed realized capital losses and unrealized capital depreciation on a cumulative basis. We believe that adjusted net investment income is a useful performance measure because it reflects the net investment income produced on the Company’s investments during a period without giving effect to any changes in the value of such investments and any related capital gains incentive fees between periods. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.
The following table provides an unaudited reconciliation of net investment income (the most comparable U.S. GAAP measure) to adjusted net investment income for the periods presented:For the three months ended For the years ended December 31, December 31, 2022 September 30, 2022
(unaudited)December 31, 2021 2022 2021 $ in millions, except per share data Amount Per Share Amount Per Share Amount Per Share Amount Per Share Amount Per Share GAAP net investment income $ 16.1 $ 0.52 $ 16.0 $ 0.52 $ 12.5 $ 0.42 $ 59.7 $ 1.93 $ 47.6 $ 1.67 Capital gains based incentive fee (1.1 ) (0.03 ) (3.1 ) (0.10 ) 0.2 0.01 (6.3 ) (0.20 ) 6.3 0.22 Adjusted net investment income $ 15.0 $ 0.49 $ 12.9 $ 0.42 $ 12.7 $ 0.43 $ 53.4 $ 1.73 $ 53.9 $ 1.89
Conference CallThe Company will host a webcast/conference call on Thursday, February 23, 2023 at 12:00 p.m. (Eastern Time) to discuss its financial results for the quarter and fiscal year ended December 31, 2022. Please visit Crescent BDC’s webcast link located on the Events & Presentations page of the Investor Relations section of Crescent BDC’s website for a slide presentation that complements the earnings conference call.
All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Events & Presentations page of the Investor Resources section of Crescent BDC’s website at www.crescentbdc.com. Please visit the website to test your connection before the webcast. Participants are also invited to access the conference call by dialing the following number:
Toll Free: (888) 396-8049
Conference ID: 56871279All callers will need to enter the Conference ID followed by the # sign and reference “Crescent BDC” once connected with the operator. An archived replay will be available via a webcast link located on the Investor Relations section of Crescent BDC's website.
Endnotes
Note: Numbers may not sum due to rounding.
- See “Non-GAAP Financial Measures” above for a description of this non-GAAP measure and a reconciliation from net investment income to adjusted net investment income. The Company's management uses this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believes that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends for the Company without giving effect to capital gains incentive fees. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.
- Yield excludes investments on non-accrual status.
- Unitranche loans are first lien loans that may extend deeper in a company’s capital structure than traditional first lien debt and may provide for a waterfall of cash flow priority among different lenders in the unitranche loan. In certain instances, the Company may find another lender to provide the “first out” portion of such loan and retain the “last out” portion of such loan, in which case, the “first out” portion of the loan would generally receive priority with respect to payment of principal, interest and any other amounts due thereunder over the “last out” portion that the Company would continue to hold. In exchange for the greater risk of loss, the “last out” portion earns a higher interest rate.
Crescent Capital BDC, Inc.
Consolidated Statements of Assets and Liabilities
(in thousands except share and per share data)As of
December 31, 2022As of
December 31, 2021Assets Investments, at fair value Non-controlled non-affiliated (cost of $1,235,778 and $1,150,173, respectively) $ 1,208,501 $ 1,165,897 Non-controlled affiliated (cost of $42,040 and $41,242, respectively) 43,080 51,701 Controlled (cost of $13,638 and $53,431, respectively) 11,375 52,768 Cash and cash equivalents 6,397 10,069 Restricted cash and cash equivalents 10,670 13,457 Interest and dividend receivable 9,945 6,763 Unrealized appreciation on foreign currency forward contracts 8,154 2,115 Deferred tax assets 91 42 Receivable for investments sold 5 14,871 Other assets 4,660 126 Total assets $ 1,302,878 $ 1,317,809 Liabilities Debt (net of deferred financing costs of $5,380 and $6,897) $ 654,456 $ 631,040 Distributions payable 12,664 12,664 Interest and other debt financing costs payable 8,471 5,513 Management fees payable 4,056 3,830 Incentive fees payable 3,112 6,924 Deferred tax liabilities 899 956 Payable for investment purchased 514 - Directors’ fees payable 151 114 Unrealized depreciation on foreign currency forward contracts 157 631 Accrued expenses and other liabilities 5,857 3,852 Total liabilities $ 690,337 $ 665,524 Net assets Preferred stock, par value $0.001 per share (10,000 shares authorized, zero outstanding, respectively) $ - $ - Common stock, par value $0.001 per share (200,000,000 shares authorized, 30,887,360 shares issued and outstanding, respectively) 31 31 Paid-in capital in excess of par value 675,008 666,162 Accumulated earnings (loss) (62,498 ) (13,908 ) Total net assets $ 612,541 $ 652,285 Total liabilities and net assets $ 1,302,878 $ 1,317,809 Net asset value per share $ 19.83 $ 21.12 Crescent Capital BDC, Inc.
Consolidated Statements of Operations
(in thousands except share and per share data)For the years ended December 31, 2022 2021 2020 Investment Income: From non-controlled non-affiliated investments: Interest income $ 101,751 $ 81,371 $ 66,078 Paid-in-kind interest 1,564 1,881 2,169 Dividend income 127 1,919 323 Other income 540 791 1,060 From non-controlled affiliated investments: Interest income 1,625 1,170 1,420 Paid-in-kind interest 2,106 1,235 1,456 Dividend income 5,169 2,414 2,407 Other income — 3 — From controlled investments: Interest income 745 2 — Paid-in-kind interest 732 — — Dividend income 2,358 3,200 2,200 Total investment income 116,717 93,986 77,113 Expenses: Interest and other debt financing costs 31,880 19,766 15,485 Management fees 16,344 14,118 11,438 Income based incentive fees 11,214 9,849 8,639 Capital gains based incentive fees (6,324 ) 6,324 — Professional fees 1,302 1,769 1,460 Directors’ fees 524 475 437 Other general and administrative expenses 2,660 2,628 2,544 Total expenses 57,600 54,929 40,003 Management fees waiver (229 ) (3,302 ) (4,672 ) Income based incentive fees waiver (538 ) (7,517 ) (8,639 ) Net expenses 56,833 44,110 26,692 Net investment income before taxes 59,884 49,876 50,421 (Benefit) provision for income and excise taxes 155 2,250 541 Net investment income 59,729 47,626 49,880 Net realized and unrealized gains (losses) on investments: Net realized gain (loss) on: Non-controlled non-affiliated investments 1,157 3,687 (10,889 ) Non-controlled affiliated investments 7,098 28,810 (4,314 ) Controlled investments (3,301 ) — — Foreign currency transactions (33 ) 311 (83 ) Foreign currency forward contracts 24 (193 ) — Net change in unrealized appreciation (depreciation) on: Non-controlled non-affiliated investments and foreign currency translation (43,818 ) 12,535 7,437 Non-controlled affiliated investments (9,419 ) (10,464 ) 19,686 Controlled investments (1,600 ) 602 (1,707 ) Foreign currency forward contracts 6,513 2,116 (1,324 ) Net realized and unrealized gains (losses) on investments (43,379 ) 37,404 8,806 Realized loss on asset acquisition - - (3,825 ) Net realized and unrealized gains (losses) on investments and asset acquisition (43,379 ) 37,404 4,981 Benefit (provision) for taxes on realized gain on investments (911 ) (1,177 ) 46 Benefit (provision) for taxes on unrealized appreciation (depreciation) on investments 105 (220 ) (235 ) Net increase (decrease) in net assets resulting from operations $ 15,544 $ 83,633 $ 54,672 Per common share data: Net increase (decrease) in net assets resulting from operations per share (basic and diluted): $ 0.50 $ 2.94 $ 1.98 Net investment income per share (basic and diluted): $ 1.93 $ 1.67 $ 1.80 Weighted average shares outstanding (basic and diluted): 30,887,360 28,477,771 27,681,757 About Crescent BDC
Crescent BDC is a business development company that seeks to maximize the total return of its stockholders in the form of current income and capital appreciation by providing capital solutions to middle market companies with sound business fundamentals and strong growth prospects. Crescent BDC utilizes the extensive experience, origination capabilities and disciplined investment process of Crescent. Crescent BDC is externally managed by Crescent Cap Advisors, LLC, a subsidiary of Crescent. Crescent BDC has elected to be regulated as a business development company under the Investment Company Act of 1940. For more information about Crescent BDC, visit www.crescentbdc.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.
About Crescent Capital Group
Crescent is a global credit investment manager with over $40 billion of assets under management. For over 30 years, the firm has focused on below investment grade credit through strategies that invest in marketable and privately originated debt securities including senior bank loans, high yield bonds, as well as private senior, unitranche and junior debt securities. Crescent is headquartered in Los Angeles with offices in New York, Boston, Chicago and London with more than 200 employees globally. Crescent is a part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life. For more information about Crescent, visit www.crescentcap.com. However, the contents of such website are not and should not be deemed to be incorporated by reference herein.
Contact:
Dan McMahon
daniel.mcmahon@crescentcap.com
212-364-0149
Forward-Looking StatementsThis press release, and other statements that Crescent BDC may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Crescent BDC’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions.
Crescent BDC cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which may change over time. Forward-looking statements speak only as of the date they are made, and Crescent BDC assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.
In addition to factors previously disclosed in Crescent BDC’s SEC reports and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: (1) our future operating results; (2) our business prospects and the prospects of our portfolio companies; (3) the impact of investments that we expect to make; (4) our contractual arrangements and relationships with third parties; (5) the dependence of our future success on the general economy and its impact on the industries in which we invest; (6) the financial condition of and ability of our current and prospective portfolio companies to achieve their objectives; (7) our expected financings and investments; (8) the adequacy of our cash resources and working capital, including our ability to obtain continued financing on favorable terms; (9) the timing of cash flows, if any, from the operations of our portfolio companies; (10) the impact of increased competition; (11) the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments; (12) potential conflicts of interest in the allocation of opportunities between us and other investment funds managed by our investment adviser or its affiliates; (13) the ability of our investment adviser to attract and retain highly talented professionals; (14) changes in law and policy accompanying the new administration and uncertainty pending any such changes; (15) increased geopolitical unrest, terrorist attacks or acts of war, which may adversely affect the general economy, domestic and local financial and capital markets, or the specific industries of our portfolio companies; (16) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets; (17) the unfavorable resolution of legal proceedings; and (18) the impact of changes to tax legislation and, generally, our tax position.
Crescent BDC’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC, identifies additional factors that can affect forward-looking statements.
Other Information
The information in this press release is summary information only and should be read in conjunction with Crescent BDC’s annual report on Form 10-K for the year ended December 31, 2022, which Crescent BDC filed with the U.S. Securities and Exchange Commission (the SEC) on February 22, 2023, Crescent BDC’s quarterly reports on Form 10-Q as well as Crescent BDC’s other reports filed with the SEC. A copy of Crescent BDC’s annual report on Form 10-K for the year ended December 31, 2022, Crescent BDC’s quarterly reports on Form 10-Q and Crescent BDC’s other reports filed with the SEC can be found on Crescent BDC’s website at www.crescentbdc.com and the SEC’s website at www.sec.gov.
- See “Non-GAAP Financial Measures” above for a description of this non-GAAP measure and a reconciliation from net investment income to adjusted net investment income. The Company's management uses this non-GAAP financial measure internally to analyze and evaluate financial results and performance and believes that this non-GAAP financial measure is useful to investors as an additional tool to evaluate ongoing results and trends for the Company without giving effect to capital gains incentive fees. The presentation of adjusted net investment income is not intended to be a substitute for financial results prepared in accordance with GAAP and should not be considered in isolation.